021-51111890
购物车（）
sales@molnova.cn
Nacubactam (b)
CAS No. 2007923-17-1
Nacubactam (b) ( OP 0595 | RG 6080 | RO 7079901 )
产品货号. M13133 CAS No. 2007923-17-1
Nacubactam (OP 0595、RG 6080、RO 7079901) 是一种二氮杂双环辛烷，可抑制 A 类和 C 类 β-内酰胺酶，IC50 小于 1 uM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | ￥10881 | 有现货 |
|
| 50MG | ￥14229 | 有现货 |
|
| 100MG | ￥17550 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Nacubactam (b)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Nacubactam (OP 0595、RG 6080、RO 7079901) 是一种二氮杂双环辛烷，可抑制 A 类和 C 类 β-内酰胺酶，IC50 小于 1 uM。
-
产品描述Nacubactam (OP 0595, RG 6080, RO 7079901) is a diazabicyclooctane that inhibits class A and C β-lactamases with IC50 of <1 uM, also acts as a PBP2-active antibacterial; exhibits MICs of 0.5 to 4 μg/ml for most members of the family Enterobacteriaceae, owing to inhibition of PBP2; has MICs of 1-4 mg/ml for Escherichia coli, Enterobacter, Citrobacter and Klebsiella spp; increases the antibacterial activity of cefepime in both in vitro and in vivo.Bacterial Infection Phase 1 Clinical.
-
体外实验——
-
体内实验——
-
同义词OP 0595 | RG 6080 | RO 7079901
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Antibacterial
-
研究领域Infection
-
适应症Bacterial Infection
化学信息
-
CAS Number2007923-17-1
-
分子量342.323
-
分子式C9H18N4O8S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)NOCCN.O
-
化学全称(2S, 5R)-N-(2-Aminoethoxy)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, monohydrate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Morinaka A, et al. J Antimicrob Chemother. 2015 Oct;70(10):2779-86.
2. Livermore DM, et al. J Antimicrob Chemother. 2015 Nov;70(11):3032-41.
3. Livermore DM, et al. Antimicrob Agents Chemother. 2015 Nov 9;60(1):554-60.
4. Morinaka A, et al. J Antibiot (Tokyo). 2017 Mar;70(3):246-250.
产品手册
关联产品
-
ANT3310
ANT3310 是一种广谱共价丝氨酸 β-内酰胺酶抑制剂，对 AmpC、CTX-M-15、TEM-1、OXA-48、OXA-23 和 KPC-2 的 IC50 范围为 1 nM 至 175 nM。 ANT3310可用于细菌感染的研究。
-
Lenampicillin hydroc...
一种有效的氨苄西林前药，具有增强吸收和减少副作用的作用。
-
Timcodar
timcodar is a non-FKBP12 binding macrolide derivative that is an efflux pump inhibitor with antimicrobial activity, inhibition of lipid accumulation, inhibition of Mycobacterium tuberculosis, and can be used in the study of obesity. timcodar is a non-FKBP12 binding macrolide derivative with antimicrobial activity.
